Lyell Immunopharma Files 8-K on Shareholder Votes
Ticker: LYEL · Form: 8-K · Filed: May 21, 2025 · CIK: 1806952
| Field | Detail |
|---|---|
| Company | Lyell Immunopharma, Inc. (LYEL) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Lyell Immunopharma held a shareholder vote on May 15th, details filed May 21st.
AI Summary
Lyell Immunopharma, Inc. filed an 8-K on May 21, 2025, reporting on matters submitted to a vote of security holders as of May 15, 2025. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in South San Francisco, California.
Why It Matters
This filing indicates that Lyell Immunopharma held a vote of its security holders, which could pertain to significant corporate actions or governance matters.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not contain information about financial distress or significant operational changes.
Key Players & Entities
- Lyell Immunopharma, Inc. (company) — Registrant
- May 15, 2025 (date) — Earliest event reported
- May 21, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Lyell Immunopharma's security holders?
The filing does not specify the exact matters voted upon, only that a submission to a vote of security holders occurred as of May 15, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 15, 2025.
What is Lyell Immunopharma's state of incorporation?
Lyell Immunopharma, Inc. is incorporated in Delaware.
Where are Lyell Immunopharma's principal executive offices located?
Lyell Immunopharma's principal executive offices are located at 201 Haskins Way, South San Francisco, California, 94080.
What is the SEC file number for Lyell Immunopharma?
The SEC file number for Lyell Immunopharma, Inc. is 001-40502.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Lyell Immunopharma, Inc. (LYEL).